Compile Data Set for Download or QSAR
Report error Found 101 Enz. Inhib. hit(s) with all data for entry = 1592
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159226(US9682967, 44 | US10195186, Example 46)
Affinity DataIC50: 88nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445042(CHEMBL3098767 | US9682967, 7 | US10195186, Example...)
Affinity DataIC50: 170nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445055(CHEMBL3098744 | US9682967, 43 | US10195186, Exampl...)
Affinity DataIC50: 200nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Mouse)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 220nMAssay Description:The Sortilin assay was performed in total volume of 40 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159140(US9682967, 18 | US10195186, Example 18)
Affinity DataIC50: 240nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 260nMAssay Description:The pro Sortilin assay was performed in total volume of 20 μl in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159213(US9682967, 42 | US10195186, Example 44)
Affinity DataIC50: 300nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159138(US9682967, 16 | US10195186, Example 16)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159139(US9682967, 17 | US10195186, Example 17)
Affinity DataIC50: 360nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 450nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159123(US9682967, 11 | US10195186, Example 11)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159129(US9682967, 13 | US10195186, Example 13)
Affinity DataIC50: 480nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159178(US9682967, 32 | US10195186, Example 34)
Affinity DataIC50: 490nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159154(US9682967, 23 | US10195186, Example 23)
Affinity DataIC50: 570nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159272(US9682967, 48 | US10195186, Example 50)
Affinity DataIC50: 620nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159273(US9682967, 49 | US10195186, Example 51)
Affinity DataIC50: 640nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159121(US9682967, 9 | US10195186, Example 9)
Affinity DataIC50: 700nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445044(CHEMBL3098765 | US9682967, 34 | US10195186, Exampl...)
Affinity DataIC50: 750nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159271(US9682967, 47 | US10195186, Example 49)
Affinity DataIC50: 750nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445041(CHEMBL3098768 | US9682967, 46 | US10195186, Exampl...)
Affinity DataIC50: 760nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445051(CHEMBL3098752 | US9682967, 5 | US10195186, Example...)
Affinity DataIC50: 830nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM332002(US10195186, Example 31 | 5-Bromo-N-(6-methyl-pyrid...)
Affinity DataIC50: 970nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159146(US9682967, 20 | US10195186, Example 20)
Affinity DataIC50: 990nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159117(US9682967, 8 | US10195186, Example 8)
Affinity DataIC50: 1.00E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159210(US9682967, 41 | US10195186, Example 43)
Affinity DataIC50: 1.10E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445058(CHEMBL3098741 | US9682967, 2 | US10195186, Example...)
Affinity DataIC50: 1.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159232(US9682967, 45 | US10195186, Example 47)
Affinity DataIC50: 1.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159166(US9682967, 28 | US10195186, Example 29)
Affinity DataIC50: 1.30E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159188(US9682967, 35 | US10195186, Example 37)
Affinity DataIC50: 1.30E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445057(CHEMBL3098742 | US9682967, 4 | US10195186, Example...)
Affinity DataIC50: 1.40E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445047(CHEMBL3098760 | US9682967, 22 | US10195186, Exampl...)
Affinity DataIC50: 1.60E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159189(US9682967, 36 | US10195186, Example 38)
Affinity DataIC50: 1.60E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159143(US9682967, 19 | US10195186, Example 19)
Affinity DataIC50: 1.70E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159126(US9682967, 12 | US10195186, Example 12)
Affinity DataIC50: 1.80E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445045(CHEMBL3098764 | US9682967, 25 | US10195186, Exampl...)
Affinity DataIC50: 1.80E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445054(CHEMBL3098745 | US9682967, 1 | US10195186, Example...)
Affinity DataIC50: 1.80E+3nMAssay Description:The progranulin Sortilin assay was performed in total volume of 20 μl in 50 mM Phosphate buffer pH 7.0 assay buffer containing 0.1% BSA. Varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159181(US9682967, 33 | US10195186, Example 35)
Affinity DataIC50: 2.00E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159169(US9682967, 29 | US10195186, Example 30)
Affinity DataIC50: 2.10E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159122(US9682967, 10 | US10195186, Example 10)
Affinity DataIC50: 2.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445046(CHEMBL3098761 | US9682967, 24 | US10195186, Exampl...)
Affinity DataIC50: 2.40E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159172(US9682967, 30 | US10195186, Example 32)
Affinity DataIC50: 3.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445050(CHEMBL3098753 | US9682967, 15 | US10195186, Exampl...)
Affinity DataIC50: 3.40E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM50445048(CHEMBL3098759 | US9682967, 21 | US10195186, Exampl...)
Affinity DataIC50: 3.60E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM331997(US10195186, Example 27 | 5-Bromo-N-(3-methyl-pyrid...)
Affinity DataIC50: 3.60E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159202(US9682967, 39 | US10195186, Example 41)
Affinity DataIC50: 3.60E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM331966(US10195186, Example 6 | 5-Bromo-N-(3-methyl-4,5,6,...)
Affinity DataIC50: 4.00E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159134(US9682967, 14 | US10195186, Example 14)
Affinity DataIC50: 4.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159199(US9682967, 38 | US10195186, Example 40)
Affinity DataIC50: 4.80E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159206(US9682967, 40 | US10195186, Example 42)
Affinity DataIC50: 5.20E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

TargetSortilin(Human)
H. Lundbeck

US Patent
LigandPNGBDBM159162(US9682967, 26 | US10195186, Example 26)
Affinity DataIC50: 5.50E+3nMAssay Description:The Sortilin assay was performed in total volume of 40 ul in 50 mM HEPES pH 7.4 assay buffer containing 100 mM NaCl, 2.0 mM CaCl2, 0.1% BSA and 0.1% ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: